1. Home
  2. REVB vs MYSZ Comparison

REVB vs MYSZ Comparison

Compare REVB & MYSZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REVB
  • MYSZ
  • Stock Information
  • Founded
  • REVB 2020
  • MYSZ 1999
  • Country
  • REVB United States
  • MYSZ Israel
  • Employees
  • REVB N/A
  • MYSZ N/A
  • Industry
  • REVB Biotechnology: Pharmaceutical Preparations
  • MYSZ Computer Software: Prepackaged Software
  • Sector
  • REVB Health Care
  • MYSZ Technology
  • Exchange
  • REVB Nasdaq
  • MYSZ Nasdaq
  • Market Cap
  • REVB 1.4M
  • MYSZ 1.4M
  • IPO Year
  • REVB N/A
  • MYSZ N/A
  • Fundamental
  • Price
  • REVB $0.34
  • MYSZ $1.17
  • Analyst Decision
  • REVB
  • MYSZ Strong Buy
  • Analyst Count
  • REVB 0
  • MYSZ 1
  • Target Price
  • REVB N/A
  • MYSZ $3.00
  • AVG Volume (30 Days)
  • REVB 1.7M
  • MYSZ 299.5K
  • Earning Date
  • REVB 11-08-2024
  • MYSZ 11-14-2024
  • Dividend Yield
  • REVB N/A
  • MYSZ N/A
  • EPS Growth
  • REVB N/A
  • MYSZ N/A
  • EPS
  • REVB N/A
  • MYSZ N/A
  • Revenue
  • REVB N/A
  • MYSZ $9,632,000.00
  • Revenue This Year
  • REVB N/A
  • MYSZ $45.80
  • Revenue Next Year
  • REVB N/A
  • MYSZ N/A
  • P/E Ratio
  • REVB N/A
  • MYSZ N/A
  • Revenue Growth
  • REVB N/A
  • MYSZ 43.89
  • 52 Week Low
  • REVB $0.32
  • MYSZ $1.05
  • 52 Week High
  • REVB $25.26
  • MYSZ $7.12
  • Technical
  • Relative Strength Index (RSI)
  • REVB 27.29
  • MYSZ 39.35
  • Support Level
  • REVB $0.32
  • MYSZ $1.05
  • Resistance Level
  • REVB $0.47
  • MYSZ $1.60
  • Average True Range (ATR)
  • REVB 0.08
  • MYSZ 0.15
  • MACD
  • REVB -0.02
  • MYSZ -0.01
  • Stochastic Oscillator
  • REVB 3.40
  • MYSZ 14.31

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of therapies for the prevention and treatment of disease using trained immunity. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

About MYSZ My Size Inc.

My Size Inc is a USA based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers, and licensing cloud-enabled software subscriptions, associated software maintenance and support.

Share on Social Networks: